CBRE Stock Cbre Group (CBRE, $155.39) was a top loser yesterday, falling -3.4%

GET DAILY SIGNALS

Get AI intraday signals

CBRE - Cbre Group

Loading...

Price: $155.39

Daily change: -$5.47 (-3.4%)

Daily volume: 1.6M

Capitalization: $46.2B

Industry: Real Estate Development

Cbre Group (CBRE, $155.39) was a top loser yesterday, declining to $155.39 per share. Of the 119 stocks analyzed in the Real Estate Development Industry, of them (3) exhibited an Uptrend while of them (6) were in a Downtrend.

CBRE in -0.52% downward trend, sliding for three consecutive days on January 09, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CBRE declined for three days, in of 281 cases, the price declined further within the following month. The odds of a continued downward trend are .

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 66 cases where CBRE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 19, 2025. You may want to consider a long position or call options on CBRE as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CBRE just turned positive on January 06, 2026. Looking at past instances where CBRE's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

CBRE moved above its 50-day moving average on December 09, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CBRE advanced for three days, in of 335 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 288 cases where CBRE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. CBRE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.744) is normal, around the industry mean (3.945). P/E Ratio (40.770) is within average values for comparable stocks, (54.260). Projected Growth (PEG Ratio) (0.825) is also within normal values, averaging (1.051). Dividend Yield (0.001) settles around the average of (0.047) among similar stocks. P/S Ratio (1.267) is also within normal values, averaging (6.817).